Claims
- 1. A chiral nonracemic compound of the formula:
- R.sub.1 --AR--O--CH.sub.2 --C*HX--C*HY--CH.sub.2 --O--R.sub.2
- wherein
- * denotes a chiral carbon,
- X and Y are halogens selected from the group of chlorine and fluorine, the .[.--O--CH.sub.2 --C*HX--C--HY--CH.sub.2 --O--.]. .Iadd.--O--CH.sub.2 --C*HX--C*HY--CH.sub.2 --O-- .Iaddend.segment comprises the chiral proximal segment of the chiral tails, said proximal segment being selected from the enantiomers 2R,3R-dihalo and 2S,3S-dihalo,
- R.sub.1 is an achiral alkyl, alkyl sulfide, alkyl ether, alkenyl, alkenyl sulfide, alkenyl ether, alkoxy, alkoxy sulfide, or alkoxy ether group of two to sixteen carbons,
- Ar is an achiral FLC core selected from the group consisting of phenylbenzoates, phenylpyrimidines, biphenyls, phenylpyridines, biphenylbenzoates, diphenylpyrimidines, diphenylpyridines, terphenyls, phenyldiazenes, diphenyldiazenes, and diphenylthiadiazoles, and the chiral proximal segment and R.sub.1 para-substituted with respect to each other on outer rings of said core, and R.sub.2 is a distal segment of the chiral tail comprising one to ten carbon atoms and is selected from the group consisting of alkdehyde, alkyl acyl, alkyl, alkenyl, alkenyl acyl, alkyl halide, alkenyl halide, alkyl epoxide, and alkenyl epoxide.
- 2. The compound of claim 1, wherein R.sub.1 comprises five to sixteen carbons.
- 3. The compounds of claim 4, wherein R.sub.1 comprises eight carbons.
- 4. The compound of claim 1, wherein R.sub.1 is selected from the group of straight-chain or branched.
- 5. The compound of claim 1, wherein R.sub.2 comprises three carbons.
- 6. The compound of claim 1, wherein R.sub.2 is selected from the group of straight-chain and branched.
- 7. The compound of claim 1, wherein R.sub.2 comprises a chiral carbon.
- 8. The compound of claim 1, wherein R.sub.2 is an alkyl halide consisting of two halogens.
- 9. The compound of claim 1, wherein said alkyl halides comprise fluorine or chlorine.
- 10. The compound of claim 1, wherein said composition is selected from the group consisting of .[.4'-[(2R,3R-difluoro-4-formyl)-butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-4'-(2R,3R-difluoro-4-formyloxybutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(X); .[.4'-[(2R,3R-difluoro-4-acetyl)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-acetoxybutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(XI); .[.4'-[(2R,3R-difluoro-4-acetyl)butyloxy]phenyl-4-heptylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-acetoxybutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XII); .[.4'-[(2R,3R-difluoro-4-propanoate)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-propanoatebutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(XIII); .[.4'-[(2R,3R-difluoro-4-butanoate)-butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-butanoatebutyloxy)phenyl]-5-hexylpyrimidine .Iaddend.(XIV); .[.4'-[(2R,3R-difluoro-4-pentanoate)butyloxy]phenyl-4-heptylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-pentanoatebutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XV); .[.4'-[2R,3R-difluoro-4-(4-pentanoate)-butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(pent-4-enoate)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XVI); .[.4'-[2R,3R-difluoro-4-methoxy)butyloxy]-phenyl-4-heptylpyrimidine.]. .Iadd.2-[4'-(2R,3R-difluoro-4-methoxybutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XVII); .[.4'-[(2R,3R-difluoro-4-butyloxy) butanoxy]phenyl-4-heptylpyrimidine.]. .Iadd.2-4'( 2R,3R-difluoro-4-butyloxybutyloxy)phenyl]-5-heptylpyrimidine .Iaddend.(XVIII); .[.4'-(2R,3R-difluoro-4-(4-pentenoxy)-butyloxy)phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(pent-4-enoxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XIX); .[.4'-(2R,3R-difluoro-4-(1-methylheptyloxy)buty oxy)- phenyl-4-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(R-1-methylheptyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XX); .[.4'-{[2R,3R-difluoro-4-(2R,3R-epoxy)hexyloxy]butyloxy}phenyl-4-hexylpy.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2R,3R-epoxyhexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXI); .[.4'-{[2R,3R-difluoro-4-(2S,3S-epoxy)hexyloxy]butyloxy}phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2S,3S-epoxyhexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXIII); .[.4'-[2R,3R-difluoro-4-(2S,3S-difluorohexyloxy)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2S,3S-difluorohexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXIV); and .[.4'-[2R,3R-difluoro-4-(2R,3R-difluorohexyloxy)butyloxy]phenyl-4-hexylpyrimidine.]. .Iadd.2-{4'-[2R,3R-difluoro-4-(2R,3R-difluorohexyloxy)butyloxy]phenyl}-5-hexylpyrimidine .Iaddend.(XXII).
- 11. An FLC composition comprising the compound of claim 1.
Relatedness of the Application
This application is a continuation-in-part of U.S. Ser. No.164,233, filed Mar.4, 1988, now U.S. Pat. No. 5,051,506 which is incorporated herein in its entirety by reference.
Government Interests
This invention was made with partial support of the United States Government under National Science Foundation Grant no. ISI8722712. The United States Government has certain rights in this invention.
US Referenced Citations (10)
Foreign Referenced Citations (12)
Number |
Date |
Country |
0220747 |
May 1987 |
EPX |
0225236 |
Feb 1988 |
EPX |
0263437 |
Apr 1988 |
EPX |
0267585 |
May 1988 |
EPX |
0269062 |
Jun 1988 |
EPX |
0278665 |
Aug 1988 |
EPX |
62-111939 |
May 1987 |
JPX |
62-258361 |
Nov 1987 |
JPX |
63-264573 |
Nov 1988 |
JPX |
8606373 |
Nov 1986 |
WOX |
8705018 |
Aug 1987 |
WOX |
8902425 |
Mar 1989 |
WOX |
Non-Patent Literature Citations (2)
Entry |
Furukawa et al. (1988) Ferroelectrics 85:451-459. |
Chemical Abstract No. 109:201686w (p. 795). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
164233 |
Mar 1988 |
|
Reissues (1)
|
Number |
Date |
Country |
Parent |
556656 |
Jul 1990 |
|